International Conference Addresses Drug-Resistant TB Epidemic Ravaging Russia

September 02, 1998

Sept. 2, 1998 -- An epidemic of multi-drug resistant, or MDR, tuberculosis (TB) is sweeping through the prison system of the former Soviet Union. The subsequent spread of regular and MDR-TB to the civilian populations has pushed Russia, Latvia and Estonia to the World Health Organization's top 10 list of global TB hot spots. With international travel, the disease can easily spread to Western Europe and other countries, increasing their health care burdens. When a relatively small outbreak of MDR-TB hit New York City, some 600 cases in the early 1990s, the city spent $1 billion in four years to bring it under control.

To address this growing problem, the Public Health Research Institute (PHRI) is hosting an International Workshop on TB in Russia on Monday, Sept. 7, 1998 in Moscow from 10 a.m. to 5 p.m. (2 a.m. to 9 a.m. E.D.T.) at the Moscow Academy of Sciences. Participants will include representatives from the Russian Ministry of Health, Russian Regional Departments of Health, the Russian national and regional prison administration, WHO, Doctors Without Borders (Medicins sans Frontiers), the Medical Emergency Relief Network International (MERLIN), the Central Tuberculosis Research Institute in Moscow, the New Jersey Medical School's National Tuberculosis Center and PHRI.

Journalists are invited to attend the meeting and a special backgrounder breakfast, TB in Russia -- Scarier than HIV, on Friday, Sept. 4, 1998 in Moscow at 9 a.m. (1 a.m. E.D.T.). PHRI is organizing this press opportunity with two other international non-governmental medical organizations: Doctors Without Borders (based in Belgium) and MERLIN (based in the United Kingdom).

To attend the Moscow briefing and/or the TB meeting, please contact Oksana Ivanova at 011 7 095 245-8613. To attend the meeting via a conference call or to receive an agenda please call Noonan/Russo Communications and ask for Ernie Knewitz, x 204, Marion E. Glick, x 221 or Tony Russo at x202.

The Public Health Research Institute directs a $12.3 million program, funded by Mr. George Soros, to combat emerging infectious diseases in Russia with a special emphasis on TB. The PHRI/Soros project has several pilot civilian programs in the regions of Tomsk, Ivanovo and Marii El, as well as prison programs in Tomsk, Ivanovo, Marii El, Nizhniy Novgorod and Vladimir. PHRI, based in New York City, has an office in Moscow to help coordinate these programs.

The TB epidemic stems from stretched resources, poor understanding of the risks associated with the disease and from decades of refusal to adopt the WHO standard of TB therapy used successfully around the world to contain, treat and cure TB patients. Already, one in 10 of the 1.5 million prisoners in the penal system has active TB and at least 12 percent have MDR-TB. In some prisons such as Colony No. 33 in Mariinsk of the Kemerovo region, the MDR-TB rate has reached 40 percent--the worst incidence rate of MDR TB ever recorded.
-end-


Noonan/Russo Communications

Related Tuberculosis Articles from Brightsurf:

Scientists find new way to kill tuberculosis
Scientists have discovered a new way of killing the bacteria that cause tuberculosis (TB), using a toxin produced by the germ itself.

Blocking the iron transport could stop tuberculosis
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply.

Tuberculosis: New insights into the pathogen
Researchers at the University of W├╝rzburg and the Spanish Cancer Research Centre have gained new insights into the pathogen that causes tuberculosis.

Unmasking the hidden burden of tuberculosis in Mozambique
The real burden of tuberculosis is probably higher than estimated, according to a study on samples from autopsies performed in a Mozambican hospital.

HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.

Reducing the burden of tuberculosis treatment
A research team led by MIT has developed a device that can lodge in the stomach and deliver antibiotics to treat tuberculosis, which they hope will make it easier to cure more patients and reduce health care costs.

Tuberculosis: Commandeering a bacterial 'suicide' mechanism
The bacteria responsible for tuberculosis can be killed by a toxin they produce unless it is neutralized by an antidote protein.

A copper bullet for tuberculosis
Tuberculosis is a sneaky disease, and the number one cause of death from infectious disease worldwide.

How damaging immune cells develop during tuberculosis
Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.

How many people die from tuberculosis every year?
The estimates for global tuberculosis deaths by the World Health Organisation (WHO) and the Institute for Health Metrics and Evaluation (IHME) differ considerably for a dozen countries, according to a study led by ISGlobal.

Read More: Tuberculosis News and Tuberculosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.